U.S. stocks rose to more records as they capped another winning week. The S&P 500 climbed 0.4% to set an all-time high for ...

Supported by their solid underlying businesses, impressive financials, and healthy growth prospects, these three defensive ...

These five dividend giants (plus two honorable mentions) aren't just income plays -- they're global titans with decades of ...

Edwards Lifesciences’ (NYSE:EW) stock surged Friday following a strong second-quarter 2025 earnings report that saw the ...

Alphabet Inc.'s $85B AI capex is backed by a $106B cloud backlog, showcasing tangible ROI. Click for my updated look at GOOGL ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

Biopharmaceuticals stock Gilead Sciences (NASDAQ: GILD) jumped 2.5% through 12:30 p.m. ET Friday after Needham & Co. upgraded ...

Edwards Lifesciences rose 4.3% after likewise topping Wall Street’s expectations for profit in the latest quarter. It said it ...

Palantir stock surged to all time high after receiving an Overweight rating and a $170 price target from Piper Sandler, ...

PLTR Keeps Breaking Records Palantir Technologies (NASDAQ:PLTR) closed at $154.86 per share yesterday, but is surging more ...

The S&P 500 was edging up by 0.1% in early trading, coming off its latest all-time high, and is on track to finish its fourth winning week in the last five. The Dow Jones Industrial Average was up 71 ...

Despite concerns about tariff-related headwinds, Deckers reported strong growth on the top and bottom lines in the first ...